Roidipedia.Compound reference & reporting
06 AUG 2026
CompoundsResearch chemical 2C-B
Research chemicalResearch chemicalPhenethylaminePsychedelic

2C-B

Also known as Nexus · Bees · Venus

2C-B is a psychedelic phenethylamine of the 2C-x family, first synthesised by Alexander Shulgin. It produces a mix of psychedelic visual effects and mild entactogenic warmth, sitting between classic psychedelics and MDMA in character, with a moderate duration of around 4-6 hours. It is the best known and most widely used 2C compound.

01 Overview

2C-B is a ring-substituted phenethylamine acting mainly as a serotonin 5-HT2A receptor partial agonist. Users describe visual enhancement, colourful patterning, bodily and tactile intensification and a sociable, sometimes euphoric headspace that is often gentler than LSD. Dose is strongly non-linear: a small increase can shift the experience from mild and sensual to intensely psychedelic, so careful measurement matters.

Formal human research is limited to a small number of pharmacology studies and survey data; most knowledge is anecdotal or from harm-reduction sources. Physical risks include nausea, vasoconstriction and, at higher doses, anxiety and confusion. It is widely mis-sold, and powders/pills labelled 2C-B may contain other, more dangerous substances.

02 Mechanism

Partial agonist at serotonin 5-HT2A receptors (with 5-HT2C activity), the shared mechanism of the classic serotonergic psychedelics.

03 Dosing

TierDoseRouteNotes
Threshold5–10 mgOralMild sensory and body effects.
Common15–25 mgOralFull psychedelic-entactogenic effect; dose-response is steep.
Strong25–40 mgOralIntense visuals; higher anxiety and nausea risk. Insufflated doses are lower and harsher.

04 Effects

EffectMagnitudeEvidence
Visual enhancement and psychedeliaColour enhancement, geometric patterning and visual movement.Anecdotal
Entactogenic warmthSociability, tactile enhancement and mild MDMA-like emotional openness.Anecdotal
Euphoria and mood liftPositive mood and energy at common doses.Anecdotal

05 Side effects

EffectSeverityFrequencyEvidenceCountermeasures
Nausea and gastrointestinal upsetNausea, occasionally vomiting, especially during onset.MildCommonAnecdotal
Vasoconstriction and cardiovascular strainPeripheral vasoconstriction, raised heart rate and blood pressure; a concern for those with cardiovascular disease.ModerateCommonAnecdotal
Anxiety and psychological distressAnxiety, confusion or a difficult experience, particularly at high or misjudged doses.ModerateCommon at higher dosesAnecdotal

07 References

2C-B: pharmacology and human effectsPubMed
2C-B drug profileEUDA (formerly EMCDDA)

08 Discussion0 comments

?
Sign in to add a comment…
Create account
Discussion is moderated. No sourcing, vendor names or price talk — those comments are removed, and repeat posts are banned.
This page is reference information, not medical advice. Doses and protocols are documented as they appear in the clinical literature and in practice — describing them is not a recommendation to use them. Countermeasures listed here are not a substitute for a physician. Legal status varies by jurisdiction and changes.